title: The association of RBC sodium-lithium countertransport (Vmax) with left ventricular mass in African American women.
abstract: In Caucasian hypertensives and diabetics, increased RBC sodium-lithium countertransporter activity (SLC) is a marker for end-organ complications of vascular disease. A subgroup of African Americans with high Vmax for SLC show strong correlations with dyslipidaemia, insulin resistance, microalbuminuria and higher blood pressure. The purpose of our study was to determine if Vmax in premenopausal African American women correlates with left ventricular mass (LVM) before the onset of clinically diagnosed hypertension. Non-diabetic African American women (n = 35, mean age 31 years) were evaluated for cardiovascular disease risk factors, including anthropometric and blood pressure measurements, oral glucose tolerance test (OGTT), and euglycaemic hyperinsulinaemic clamp for insulin sensitivity. Fasting blood specimens were assayed for SLC activity (Vmax) and lipids. Cardiac structure was determined by 2-D echocardiography. LVM was calculated by the cube root formula and adjusted for height (LVM index). Vmax correlated significantly with average systolic blood pressure (r = 0.45, P = 0.007), diastolic blood pressure (r = 0.48, P = 0.004), mean blood pressure (r = 0.48, P = 0.003) and LVM index (r = 0.40, P = 0.02). Vmax was also associated with fasting insulin (r = 0.39, P = 0.01), the sum of insulin (r = 0.52, P = 0.002), and insulin sensitivity adjusted for fat-free mass (r = -0.55, P = 0.001). There was no statistically significant relationship between Vmax and body mass or lipids. Vmax for SLC correlates with cardiac structure in premenopausal African American women. Vmax is also associated with insulin sensitivity and insulin resistance in this non-diabetic sample. SLC activity may be useful in identifying a subgroup of young African American women with left ventricular hypertrophy and insulin resistance before the onset of clinically diagnosed hypertension and diabetes. Journal of Human Hypertension (2000) 14, 213-219.
authors.affiliation: MCP Hahnemann University, PA 19129, USA.
authors.forename: K
authors.initials: K
authors.lastname: Sherif
authors.forename: M
authors.initials: M
authors.lastname: Barrett
authors.forename: H
authors.initials: H
authors.lastname: Kushner
authors.forename: B
authors.initials: B
authors.lastname: Falkner
mesh_terms: D000328:Adult; D017920:Antiporters / Q000097:blood*; D044383:Black People; D001794:Blood Pressure; D003971:Diastole; D004452:Echocardiography; D004912:Erythrocytes / Q000378:metabolism*; D005260:Female; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000097:blood / Q000000981:diagnostic imaging* / Q000503:physiopathology; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance; D013599:Systole; D001741:Black or African American
chemical_list: D017920:Antiporters; D007328:Insulin; C045885:sodium-lithium countertransporter